Chembond Chemicals Ltd has informed the Exchange about Apportionment of Cost of Acquistion of Equity Shares of Chembond Chemicals Limited and Chembond Chemical Specialties Limited pursuant to Composite Scheme of Arrangement.
CHEMBOND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chembond Chemicals Limited has informed exchanges about how shareholders should split their original cost of acquisition between the Demerged Company (CCL) and the Resulting Company (CCSL) after the NCLT-sanctioned Composite Scheme of Arrangement (order dated April 7, 2025). Under the scheme, the Demerged Undertaking has been demerged into Chembond Chemical Specialties Limited, with shareholders receiving 2 equity shares of CCSL (face value Rs 5) for every 1 share held in CCL (face value Rs 5), with the record date being May 9, 2025. The original acquisition cost is to be apportioned as 69.25% to CCL and 30.75% to CCSL. The demerger qualifies as tax-neutral under Section 2(19AA) of the Income Tax Act, meaning shareholders do not face any tax on this restructuring, and the original acquisition date carries over to the new shares.
Shareholders should update their tax records to reflect the 69.25%/30.75% cost split for future capital gains calculations. This is an administrative/tax communication following an already-approved restructuring and is unlikely to cause any fresh stock price movement on its own.